Selinexor and Low Dose Dexamethasone (Sd) in Patients with Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib and Anti-CD38 Ab Refractory Multiple Myeloma (MM): STORM Study

Overview of attention for article published in Blood, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent: 5 patents

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Crystalline form of Selinexor

Grant US-12709609-B2

United States of America

18 Aug 2026

Nuclear transport modulators and uses thereof

Grant US-12577225-B2

United States of America

17 Mar 2026

Polymorphs of Selinexor

Grant US-12371420-B2

United States of America

29 Jul 2025

Methods of determining IMiDS resistance in plasma cell disorders

Grant US-10697024-B2

United States of America

30 Jun 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.